Progyny Inc (PGNY)
32.28
+0.22
(+0.69%)
USD |
NASDAQ |
May 01, 16:00
32.28
0.00 (0.00%)
After-Hours: 20:00
Progyny Cash from Investing (Quarterly): -93.41M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -93.41M |
September 30, 2023 | -64.32M |
June 30, 2023 | -58.92M |
March 31, 2023 | 16.13M |
December 31, 2022 | -1.173M |
September 30, 2022 | -1.876M |
June 30, 2022 | -1.259M |
March 31, 2022 | -39.56M |
December 31, 2021 | -6.312M |
September 30, 2021 | 22.37M |
Date | Value |
---|---|
June 30, 2021 | 31.22M |
March 31, 2021 | -38.52M |
December 31, 2020 | 11.89M |
September 30, 2020 | -9.148M |
June 30, 2020 | -42.08M |
March 31, 2020 | -0.693M |
December 31, 2019 | -2.278M |
September 30, 2019 | -0.42M |
June 30, 2019 | -0.133M |
March 31, 2019 | 0.075M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-93.41M
Minimum
Dec 2023
31.22M
Maximum
Jun 2021
-14.66M
Average
-1.876M
Median
Sep 2022
Cash from Investing (Quarterly) Benchmarks
Delcath Systems Inc | -19.67M |
Star Equity Holdings Inc | -3.321M |
Exact Sciences Corp | -66.77M |
Illumina Inc | -85.00M |
CytoSorbents Corp | -0.1359M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 37.66M |
Cash from Financing (Quarterly) | -5.025M |
Free Cash Flow | 185.17M |
Free Cash Flow Per Share (Quarterly) | 0.366 |
Free Cash Flow to Equity (Quarterly) | 36.98M |
Free Cash Flow to Firm (Quarterly) | 36.98M |
Free Cash Flow Yield | 5.70% |